Big news last week from one of your positions. We could quickly see a COVID-19 vaccine approved by the end of the day today. Your position’s up another 20% this morning and is continuing to climb. Take action now and book those gains!
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Here’s a catalyst nobody could possibly miss: Mass COVID-19 vaccinations are going to open the world back up and advance the throttles on the economy in a way we haven’t experienced in more than a year. And today’s play allows you to capitalize on this event.
On Thursday, I told you about a major catalyst taking shape in your battery trade. This morning, shares are up 20%. But is it still time to buy into this play?
The chip shortage is becoming a big problem. And it’s affecting automakers unlike anything the world has yet to see. Today’s play looks to capitalize on that effect.
It’s been quite a week. On Monday we got a very big curveball that changed everything… Today, we’ll sell our election havoc hedge and pivot into a COVID-19 vaccine play with a major catalyst coming up this month.
Today there is a big catalyst play I would like to share. It is a biotech that has an important catalyst date coming up at the end of next month. Now is the time to get in....
I’m excited to add a new potential biotech catalyst to our portfolio this week! This tiny biotech stock just uplisted onto the Nasdaq eight days ago — and I think that it’s set to get more mainstream attention from Wall Street. Before it does, I want to put it on your radar.